[Effect of cytosine-arabinoside in hemoblastoses].
D001855:Bone Marrow Diseases / Q000188:drug therapy*; D003561:Cytarabine / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy; D007962:Leukocytes; D008297:Male; D008875:Middle Aged; D009000:Monocytes; D011086:Polycythemia / Q000150:complications
D003561:Cytarabine
K úcinku cytosin-arabinosidu u hemoblastos.